Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119


Adverse effects of falciparum and vivax malaria and the safety of antimalarial treatment in early pregnancy: a population-based study.

McGready R, Lee SJ, Wiladphaingern J, Ashley EA, Rijken MJ, Boel M, Simpson JA, Paw MK, Pimanpanarak M, Mu O, Singhasivanon P, White NJ, Nosten FH.

Lancet Infect Dis. 2012 May;12(5):388-96. doi: 10.1016/S1473-3099(11)70339-5.


Effects of Plasmodium vivax malaria in pregnancy.

Nosten F, McGready R, Simpson JA, Thwai KL, Balkan S, Cho T, Hkirijaroen L, Looareesuwan S, White NJ.

Lancet. 1999 Aug 14;354(9178):546-9.


Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study.

Moore KA, Simpson JA, Paw MK, Pimanpanarak M, Wiladphaingern J, Rijken MJ, Jittamala P, White NJ, Fowkes FJ, Nosten F, McGready R.

Lancet Infect Dis. 2016 May;16(5):576-83. doi: 10.1016/S1473-3099(15)00547-2.


Thrombocytopaenia in pregnant women with malaria on the Thai-Burmese border.

Tan SO, McGready R, Zwang J, Pimanpanarak M, Sriprawat K, Thwai KL, Moo Y, Ashley EA, Edwards B, Singhasivanon P, White NJ, Nosten F.

Malar J. 2008 Oct 15;7:209. doi: 10.1186/1475-2875-7-209.


Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.

Carrara VI, Lwin KM, Phyo AP, Ashley E, Wiladphaingern J, Sriprawat K, Rijken M, Boel M, McGready R, Proux S, Chu C, Singhasivanon P, White N, Nosten F.

PLoS Med. 2013;10(3):e1001398. doi: 10.1371/journal.pmed.1001398.


Malaria treatment and prevention in pregnancy: indications for use and adverse events associated with use of chloroquine or mefloquine.

Steketee RW, Wirima JJ, Slutsker L, Khoromana CO, Heymann DL, Breman JG.

Am J Trop Med Hyg. 1996;55(1 Suppl):50-6.


Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.

Phyo AP, Jittamala P, Nosten FH, Pukrittayakamee S, Imwong M, White NJ, Duparc S, Macintyre F, Baker M, Möhrle JJ.

Lancet Infect Dis. 2016 Jan;16(1):61-9. doi: 10.1016/S1473-3099(15)00320-5.


The effects of quinine and chloroquine antimalarial treatments in the first trimester of pregnancy.

McGready R, Thwai KL, Cho T, Samuel, Looareesuwan S, White NJ, Nosten F.

Trans R Soc Trop Med Hyg. 2002 Mar-Apr;96(2):180-4.


Intervals to Plasmodium falciparum recurrence after anti-malarial treatment in pregnancy: a longitudinal prospective cohort.

Laochan N, Zaloumis SG, Imwong M, Lek-Uthai U, Brockman A, Sriprawat K, Wiladphaingern J, White NJ, Nosten F, McGready R.

Malar J. 2015 May 28;14:221. doi: 10.1186/s12936-015-0745-9.


Chloroquine prophylaxis against vivax malaria in pregnancy: a randomized, double-blind, placebo-controlled trial.

Villegas L, McGready R, Htway M, Paw MK, Pimanpanarak M, Arunjerdja R, Viladpai-Nguen SJ, Greenwood B, White NJ, Nosten F.

Trop Med Int Health. 2007 Feb;12(2):209-18.


Malaria parasite infection during pregnancy and at delivery in mother, placenta, and newborn: efficacy of chloroquine and mefloquine in rural Malawi.

Steketee RW, Wirima JJ, Slutsker L, Roberts JM, Khoromana CO, Heymann DL, Breman JG.

Am J Trop Med Hyg. 1996;55(1 Suppl):24-32.


Drugs for preventing malaria in pregnant women in endemic areas: any drug regimen versus placebo or no treatment.

Radeva-Petrova D, Kayentao K, ter Kuile FO, Sinclair D, Garner P.

Cochrane Database Syst Rev. 2014 Oct 10;(10):CD000169. doi: 10.1002/14651858.CD000169.pub3. Review.


Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative.

Carrara VI, Sirilak S, Thonglairuam J, Rojanawatsirivet C, Proux S, Gilbos V, Brockman A, Ashley EA, McGready R, Krudsood S, Leemingsawat S, Looareesuwan S, Singhasivanon P, White N, Nosten F.

PLoS Med. 2006 Jun;3(6):e183.


Dihydroartemisinin-piperaquine treatment of multidrug resistant falciparum and vivax malaria in pregnancy.

Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Sugiarto P, Tjitra E, Anstey NM, Price RN.

PLoS One. 2014 Jan 17;9(1):e84976. doi: 10.1371/journal.pone.0084976.


Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics.

Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, Singhasivanon P, White NJ, Price RN.

Clin Infect Dis. 2011 Mar 1;52(5):612-20. doi: 10.1093/cid/ciq249.


Chloroquine pharmacokinetics in pregnant and nonpregnant women with vivax malaria.

Lee SJ, McGready R, Fernandez C, Stepniewska K, Paw MK, Viladpai-nguen SJ, Thwai KL, Villegas L, Singhasivanon P, Greenwood BM, White NJ, Nosten F.

Eur J Clin Pharmacol. 2008 Oct;64(10):987-92. doi: 10.1007/s00228-008-0500-z.


Prevalence and risk factors for Plasmodium falciparum malaria in pregnant women attending antenatal clinic in Bobo-Dioulasso (Burkina Faso).

Cisse M, Sangare I, Lougue G, Bamba S, Bayane D, Guiguemde RT.

BMC Infect Dis. 2014 Nov 19;14:631. doi: 10.1186/s12879-014-0631-z.


The effect of malaria and malaria prevention in pregnancy on offspring birthweight, prematurity, and intrauterine growth retardation in rural Malawi.

Steketee RW, Wirima JJ, Hightower AW, Slutsker L, Heymann DL, Breman JG.

Am J Trop Med Hyg. 1996;55(1 Suppl):33-41.


Adverse pregnancy outcomes in an area where multidrug-resistant plasmodium vivax and Plasmodium falciparum infections are endemic.

Poespoprodjo JR, Fobia W, Kenangalem E, Lampah DA, Warikar N, Seal A, McGready R, Sugiarto P, Tjitra E, Anstey NM, Price RN.

Clin Infect Dis. 2008 May 1;46(9):1374-81. doi: 10.1086/586743.


The effects of Plasmodium falciparum and P. vivax infections on placental histopathology in an area of low malaria transmission.

McGready R, Davison BB, Stepniewska K, Cho T, Shee H, Brockman A, Udomsangpetch R, Looareesuwan S, White NJ, Meshnick SR, Nosten F.

Am J Trop Med Hyg. 2004 Apr;70(4):398-407.

Items per page

Supplemental Content

Support Center